Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· February 3, 2026

Earnings live: AMD, Chipotle stocks fall, Mondelez profits hit by high cocoa prices

View original at finance.yahoo.com
Earnings live: AMD, Chipotle stocks fall, Mondelez profits hit by high cocoa prices The fourth quarter earnings season momentum continues this week, with results from Alphabet (GOOG, GOOGL), Amazon (AMZN), AMD (AMD), Qualcomm (QCOM), and Palantir (PLTR) highlighting the calendar…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Cattle supply is expected to remain tight throughout 2026 and 2027

    80% confidence
  • Q4 loss reflects a softer macro environment and lower industry trading volumes and onchain activity

    80% confidence
  • Throughout 2025, NXP executed effectively despite a challenging first half, maintaining operational discipline while advancing strategic priorities

    80% confidence
  • There's no guarantee Palantir won't be disrupted by AI but the company's investments in AI are paying off

    80% confidence
  • Mondelez is in a transitional phase as it seeks to stabilize volume declines and reinvest in its brands

    80% confidence
  • Tyson expects adjusted operating income between $2.1 billion and $2.3 billion for 2026

    80% confidence
  • Beef volume shortfall was roughly 133 million pounds from Q4 to Q1, offset by growth in chicken, pork, prepared business, and international

    80% confidence
  • Tyson expects 2026 sales to increase 2% to 4% year over year

    80% confidence
  • Cattle supply is down 1% compared to last year

    80% confidence
  • Galaxy Digital remains on track to deliver 133MW of critical IT load to CoreWeave in the first half of 2026

    80% confidence
  • PepsiCo reiterated its 2026 forecast

    80% confidence
  • Mondelez expects 2026 adjusted earnings per share growth to be flat to up 5%

    80% confidence
  • ExxonMobil is a fundamentally stronger company than it was a few years ago, with transformation delivering a more resilient, lower-cost, technology-led business

    80% confidence
  • If the 11.9% EPS growth rate holds, it would represent the 10th consecutive quarter of annual earnings growth and fifth consecutive quarter of double-digit growth

    80% confidence
  • NXP forecasts Q1 2026 revenue of $3.15 billion at midpoint and diluted EPS of $4.21

    80% confidence
  • Tyson expects chicken operating income between $1.65 billion and $1.9 billion in 2026

    80% confidence
  • Tyson expects beef operating loss between $250 million and $500 million in 2026, excluding facility closure

    80% confidence
  • Mondelez expects 2026 net revenue growth to be flat to up 2%

    80% confidence
  • Chipotle expects no sales growth in 2026 as it navigates declining traffic

    80% confidence
  • Exxon plans to spend $27 billion to $29 billion in capital expenditures in 2026

    80% confidence
  • Prices paid for cattle were at an all-time high

    80% confidence
  • 33% of S&P 500 companies have reported Q4 results as of Jan 30, with analysts estimating 11.9% earnings per share increase

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com